Takeda Pharmaceutical (4502.T) Net Income
Price: $4526
Market Cap: $7.17T
Avg Volume: 4.10M
Market Cap: $7.17T
Avg Volume: 4.10M
Country: JP
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
What is Takeda Pharmaceutical's Net Income?
- Takeda Pharmaceutical's annual net income as of FY 2023 is $144.07B.
- Takeda Pharmaceutical's quarterly net income as of Q3 2024 is $23.79B.
What is Net Income?
Net income is the total profit of a company after all expenses and taxes have been deducted from revenue. It is also known as net profit or net earnings and is a key indicator of a company's financial performance and profitability.
Related Metrics
Other important metrics to assess Takeda Pharmaceutical's financial health include:
- Net Income Growth - the rate at which a company's net income is growing:
- Annual Growth: -54.56%
- Net Income Ratio - net income divided by revenue:
- Annual: 3.38%
- Quarterly: 2.08%
- Net Income Per Share - net income divided by the number of shares outstanding:
- Annual: $92.09
These metrics provide insights into Takeda Pharmaceutical's financial health and its profitability. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.
Annual Net Income
$144.07B
Quarterly Net Income
$23.79B
Historical Annual Net Income
Historical Quarterly Net Income
Annual Net Income Growth
Annual Net Income Per Share
Takeda Pharmaceutical Historical Net Income Metrics
The table below shows various financial metrics for each year, with the latest data available for the last fiscal year 2024.
| Year | Net Income | Net Income Growth | Net Income Ratio | Net Income Per Share |
|---|---|---|---|---|
| 2024 | $144.07B | -54.56% | 3.38% | $92.09 |
| 2023 | $317.02B | 37.80% | 7.87% | $204.29 |
| 2022 | $230.06B | -38.81% | 6.45% | $147.14 |
| 2021 | $376.00B | 749.90% | 11.76% | $240.72 |
| 2020 | $44.24B | -59.46% | 1.34% | $28.41 |
| 2019 | $109.13B | -41.61% | 5.20% | $69.57 |
| 2018 | $186.89B | 62.59% | 10.56% | $119.15 |
| 2017 | $114.94B | 43.38% | 6.64% | $73.28 |
| 2016 | $80.17B | 154.99% | 4.44% | $51.11 |
| 2015 | $-145.78B | -236.68% | -8.20% | $-92.94 |